Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation in an Exclusive Segment on Fox Business Network airing on...
Recent reports of Nipah virus (NiV) infections in West Bengal, India, have reignited global concern, prompting public health authorities to prioritize research into this high-mortality pathogen. In response, Sino Biological,...
The sale of the diabetes care business, initially announced on April 22, 2025, has been completed. This is a strategic milestone for Ypsomed as it refocuses on its market-leading position...
In 2026, Italvacuum will engage with the global pharmaceutical community through its participation in a series of international events focused on pharmaceutical manufacturing, processing, and quality-driven production environments. The company...
The US Food and Drug Administration (FDA) has granted 510(k) clearance for SmartPilot, a digital connectivity add-on developed by Ypsomed. The device transforms the YpsoMate autoinjector into a connected system...
Sino Biological, Inc. is proud to announce the launch of its innovative SwiftFluo® TR-FRET Kinase Assay Kits, a ready-to-use, high-performance solution designed to accelerate kinase activity detection and high-throughput kinase...
Pharmaceutical packaging has always been defined by innovation, barrier protection, sterility assurance, and tamper-evident seals. Yet when it comes to the most fundamental requirement of all, proving that packaging is...
At its Capital Markets Day at Ypsomed’s manufacturing plant in Schwerin, Germany, on Monday, September 29, 2025, Ypsomed announced its key strategic priorities and mid-term ambition. The company is pursuing...
Ypsomed celebrated the topping-out ceremony for its second plant in Schwerin with over 200 guests from politics, business, and the construction trade. With 'Schwerin 2,' the company is investing more than...
Ypsomed will establish its first manufacturing facility in the US. The company has selected Holly Springs in Wake County, North Carolina, as the location, and will invest around CHF200m in...
